NCT07514286 Assessment of the Feasibility and Organisational Impact of a Care Pathway Incorporating the MultiSense® Medical Device for Post-operative Home Monitoring of Elderly Patients.
| NCT ID | NCT07514286 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rhythm Diagnostic Systems |
| Condition | Average Length of Stay |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-06-03 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-06-03 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assessing the clinical and organisational impact of a home-based post-operative monitoring strategy incorporating the MultiSense® device involving 80 patients aged 65 years and over who have undergone major surgery.
Eligibility Criteria
Inclusion Criteria : * Patient aged 65 or over * Patient eligible for remote monitoring using the MultiSense® device * No psychiatric illness that would prevent them from giving informed consent or receiving optimal treatment and follow-up care * Subject affiliated with a health insurance scheme * Subject able to read and understand English * Subject who has signed an informed consent form * Subjects indicated for scheduled surgery * Patients indicated for scheduled surgery : * Transverse colectomy, by laparotomy * Hepatic laparoscopy * Laparoscopic or laparoscopic liver surgery (code hlfc or hlfa for procedures) * Hysterectomy * Adnexectomy * Parietal surgery (eventration) * Rectal resection * Right and left colectomy * Stoma closure by direct approach Exclusion Criteria : * Patients already participating in an interventional clinical trial. * Patients subject to legal protection measures, guardianship, curatorship, or deprived of their liberty by judicial or administrative decision. * Patients hospitalised without consent. * Patients unable to complete a questionnaire and without a close relative to assist them in using the solution. * Patients admitted to or residing in a health or social care facility (other than for the surgery itself). * Persons admitted to or residing in a health or social care institution (other than for the surgery itself); * Persons unable to give their free and informed consent.
Frequently Asked Questions
Who can join the NCT07514286 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Average Length of Stay. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07514286 currently recruiting?
Yes, NCT07514286 is actively recruiting participants. Visit ClinicalTrials.gov or contact Rhythm Diagnostic Systems to inquire about joining.
Where is the NCT07514286 trial being conducted?
This trial is being conducted at Angers, France, Bordeaux, France, Mont-de-Marsan, France, Nantes, France.
Who is sponsoring the NCT07514286 clinical trial?
NCT07514286 is sponsored by Rhythm Diagnostic Systems. The trial plans to enroll 80 participants.